Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Grant Opportunities
Support

Search results

Puberty Suppression in Adolescents With Gender Identity Disorder: A Prospective Follow‐Up Study

August 1, 2011
Studies

SEGM Summary:

Background: Dutch clinicians hypothesized that transgender adults would have better psychological outcomes if they received earlier intervention. They proposed an intervention model consisting of puberty blockers, cross-sex hormones, and genital and non-genital surgeries to...

Matched fragments:
… Introduction. Puberty suppression by means of … gender dysphoria before and after puberty suppression in gender … eligible candidates who received puberty suppression between 2000 and …

Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment

October 1, 2014
Studies
BACKGROUND: In recent years, puberty suppression by means of gonadotropin-releasing hormone analogs has become accepted in clinical management of adolescents who have gender dysphoria (GD). The current study is the first longer-term longitudinal evaluation of the effectiveness of this approach....
Matched fragments:
… BACKGROUND: In recent years, puberty suppression by means of … and 33 transmen) who had received puberty suppression during … 3 times: before the start of puberty suppression (mean age, 13.6 …

Fact-Checking the HHS

April 7, 2022
Spotlight
Last week, the U.S. Department of Health and Human Services (HHS) issued an official document entitled "Gender-Affirming Care and Young People". The document purported that the use of “gender-affirming” hormonal and surgical interventions for youth struggling with gender dysphoria is “crucial to...
Matched fragments:
… to endocrine interventions (puberty blockers and cross sex hormones) and … claim of the reversibility of puberty blockers. The document …

Buying time or arresting development? The dilemma of administering hormone blockers in trans children and adolescents:

September 1, 2017
Studies
In recent years, the use of gonadotropin-releasing hormone (GnRH) analogues in adolescents with gender dysphoria (GD) to suppress puberty has been adopted by an increasing number of gender clinics, generating controversial debate. This short essay provides an overview of the difficulties associated...
Matched fragments:
… gender dysphoria (GD) to suppress puberty has been adopted by an … for and against the suspension of puberty. Further, it reviews the …

The impact of suppressing puberty on neuropsychological function: A review

February 9, 2024
Studies
Aim Concerns have been raised regarding the impact of medications that interrupt puberty, given the magnitude and complexity of changes that occur in brain function and structure during this sensitive window of neurodevelopment. This review examines the literature on the impact of pubertal...
Matched fragments:
… of medications that interrupt puberty, given the magnitude and … the neuropsychological impacts of puberty blockers are complex and often sex …

Puberty Suppression for Pediatric Gender Dysphoria and the Child’s Right to an Open Future

April 2, 2024
Studies
In this essay, we consider the clinical and ethical implications of puberty blockers for pediatric gender dysphoria through the lens of “the child’s right to an open future,” which refers to rights that children do not have the capacity to exercise as minors, but that must be protected, so they can...
Matched fragments:
… and ethical implications of puberty blockers for pediatric gender … consent. We evaluate claims that puberty blockers are reversible, …

The German Guidelines for Diagnosis and Treatment of Gender Incongruence and Gender Dysphoria of Childhood and Adolescence

May 20, 2024
Spotlight
This Spotlight reviews the German Association of Scientific Medical Societies' 2024 draft guidelines for treating gender dysphoria and gender incongruence in childhood and adolescence and the role of evidence in the process of guideline development.
Matched fragments:
… Report recommended withdrawing puberty blockers from commissioned … starting cross-sex hormones. Puberty blockers (PB) . PBs can be …

De Gezondheidsraad en het reguleringsklimaat rond puberteitsremming bij minderjarigen [The Health Council and the Regulatory Climate Surrounding Puberty Suppression in Minors]

January 1, 2025
Studies
The prescription of puberty blockers to minors with gender dysphoria, as laid down in the Dutch Protocol, has increasingly become the subject of debate. Countries such as the United Kingdom and Sweden have already restricted this practice. Against this background, the House of Representatives has...
Matched fragments:
… The prescription of puberty blockers to minors with gender … controversy surrounding puberty suppression in minors, the …

Swedish Transgender Treatment Guidelines for Youth

September 24, 2024
Spotlight

Unlike Europe, where national health service (NHS) agencies regulate the practice of medicine, the decentralized nature of the US healthcare system presents a distinct challenge when it comes to healthcare regulation. This is especially evident in the case of youth gender medicine, which relies...

Matched fragments:
… original FDA approval for both puberty blockers and sex hormones dealt with … or restrictions on the use of puberty blockers and cross-sex …

2025 German Guidelines for Diagnosis and Treatment of Gender Incongruence and Gender Dysphoria of Childhood and Adolescence

March 26, 2025
Spotlight
The field of youth gender medicine remains in disarray, with increasing recognition of the harms of gender-affirming interventions clashing against continued reliance on unscientific “consensus” guidelines that bypass rigorous evidence-based standards. The German Guidelines acknowledge that most...
Matched fragments:
… government to limit the use of puberty blockers and cross-sex hormones to … companies that manufacture puberty blockers.  Further, there is …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • …
  • Next page ›
  • Last page Last »

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM